Key takeaways
- Prenatal exposure to paracetamol can increase the risk of neurological developmental disorders such as autism and ADHD in children.
- This research used a rigorous methodology and analyzed data from more than 100,000 participants.
- Health workers would be careful and limited use of paracetamol
- During pregnancy, recommend and safer alternatives to the treatment of pain must examine.
A Recent study by researchers from the ICAHN School of Medicine at Mount Sinai Suggers a possible link between prenatal exposure to paracetamol and an increased risk of neurological developmental disorders in children. This study, published in BMC Environmental Health, is the first to use the rigorous methodology of the Navigation Guide to exhaust the existing scientific literature on this subject.
Neurological developmental disorders
In collaboration with institutions such as the University of California in Los Angeles and the Harvard Th Chan School of Public Health, the team analyzed 46 studies led by Mount Sinai in which more than 100,000 participants were involved in different countries. Their findings question the long -held conviction that paracetamol, which is often used by pregnant women to relieve pain and lower fever, is completely safe during pregnancy.
The Navigation Guide methodology enables researchers to assess the quality of individual studies, to identify possible distortion and to determine the overall strength of the evidence. In particular, studies of higher quality showed a connection between prenatal exposure to paracetamol and an increased risk of autism spectrum disorders and ADHD in this analysis.
Safe pain relief during pregnancy
Dr. Diddier Prada, the main author of the investigation, points out that the investigation does not considerably reinforces the existing evidence that points to a context. Given the widespread use of paracetamol during pregnancy, even a small risk increase could have considerable consequences for public health.
Based on their findings, the researchers propose a number of recommendations: careful and limited use of paracetamol during pregnancy under medical supervision; updated clinical guidelines in which the benefits and risks are carefully weighed against each other; And further research to confirm these findings and to investigate safer alternatives for the treatment of pain in pregnant women.
Open communication
Dr. Prada emphasizes that it is important to consult care providers before medication is stopped, because untreated pain or fever can also cause risks to the fetus. The research emphasizes the need for an open discussion between expectant mothers and their doctors about the safest options to relieve pain, whereby, where possible, drug approaches are not considered.
Now the diagnoses of autism and ADHD Increase worldwide, these findings have important implications for public health policy, clinical guidelines and patient information. They also emphasize the urgent need for pharmaceutical innovation to develop safer solutions for pain relief for pregnant women.
